2:39 p.m. ET, May 27, 2021
COVAX calls on first world nations to share 1 billion vaccine doses in 2021
From CNN’s Claudia Rebaza in London
The
COVAX initiative is calling on first world nations to share 1 billion vaccine doses before the end of 2021, in order to ensure vaccines can be supplied to the poorest nations on the planet.
“At no point in this pandemic have we seen such an acute need to look to the future challenges and not rest on the patchy achievements made so far,” COVAX said in a statement on Thursday. “The terrible surge of the virus in India has had a severe impact on COVAX’s supply in the second quarter of this year, to the point where, by the end of June we will face a shortfall of 190 million doses.”
“Even though COVAX will have larger volumes available later in the year through the deals it has already secured with several manufacturers, if we do not address the current, urgent shortfall the consequences could be catastrophic,” the statement added.
In order to tackle the shortfalls and meet its targets, COVAX is requesting $2 billion in donations, by June, to lock in supplies so doses can be delivered through 2021 and 2022; and is calling on countries with the largest supplies to “redirect doses to COVAX now, to have maximum impact.”
The initiative also said it had started to see countries stepping forward, including the US and Europe, which had collectively pledged to share 180 million doses, but says it still needs more. “At least one billion doses could be shared by wealthy countries in 2021,” the statement read.
“Now more than ever, at the peak of the pandemic, we need ambitious, global solutions. When it comes to worldwide vaccine distribution, COVAX is the only initiative capable of rising to the challenge of this moment,” it said. “It’s understandable that some countries want to press ahead and vaccinate all of their populations. By donating vaccines to COVAX alongside domestic vaccination programmes, the most at-risk populations can be protected globally, which is instrumental to ending the acute phase of the pandemic, curbing the rise and threat of variants, and accelerating a return to normality."